NCT07622303Not yet recruiting
Depression, Anxiety and Sleep in Parkinson's Disease
Assessment of Depression , Anxiety and Sleep Disorders in Patients With Idiopathic Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 9 Jun 2026
Brief summary (registry, in English)
This study aims to assess the prevalence and severity of depression, anxiety, and sleep disorders among patients with idiopathic Parkinson's disease. The study will evaluate the relationship between neuropsychiatric symptoms and disease characteristics in order to improve early recognition and patient quality of life.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 24 May 2026
- Start date
- 1 Jun 2026
- Primary completion date
- 28 Feb 2027
- Lead sponsor
- Sohag University
- Diseases
- Parkinson disease
- NCT number
- NCT07622303
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Jun 2026 to the primary completion date, 28 Feb 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- A-Inclusion Criteria:
- Patients diagnosed with idiopathic Parkinson's disease according to the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease (Postuma et al., 2015).
- Age ≥ 50 years.
- Ability to understand and respond to questionnaires and rating scales.
- Ability and willingness to provide informed consent.
- B-Exclusion Criteria:
- Patients with atypical parkinsonism.
- Patients with a history of other major neurological disorders (e.g., stroke, Alzheimer's disease, multiple sclerosis).
- Patients with severe cognitive impairment or dementia that prevents reliable completion of rating scales.
- Patients with a current diagnosis of severe psychiatric disorders unrelated to 5-Parkinson's disease (e.g., schizophrenia, bipolar disorder).
- 6-Patients with unstable medical conditions. 7-Patients unable or unwilling to provide informed consent.
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.